Bayer AG (BAYN.MU)
| Previous close | 28.61 |
| Open | 28.68 |
| Bid | 28.55 x 27000 |
| Ask | 28.66 x 35000 |
| Day's range | 28.59 - 28.83 |
| 52-week range | 25.42 - 54.66 |
| Volume | |
| Avg. volume | 2,087 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
- Zacks
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
Bayer's (BAYRY) Q1 earnings and sales decline year over year due to a fall in volumes for non-glyphosate-based herbicides and lower prices for glyphosate-based products in the Crop Science division.
- Bloomberg
Vodafone, Deutsche Telekom Cash Swells: EMEA Earnings Week Ahead
(Bloomberg) -- Cost and capital spending cuts will determine the pace of earnings and cash flow growth for BT Group Plc, Deutsche Telekom AG and Vodafone Plc, reporting this week.Most Read from BloombergTrump Vows ‘Day One’ Executive Order Targeting Offshore WindChina to Start $138 Billion Bond Sale on Friday to Boost EconomyPutin Names Economist as Defense Minister in Surprise ReshuffleGlobal Chips Battle Intensifies With $81 Billion Subsidy SurgeMost of Europe’s biggest carriers have set an “o
